This inventor holds 1 USPTO granted patent. Top assignee: Bigfoot Biomedical, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stuart Helgeson and Injection Site Recommendation Technology.
Introduction
Stuart Helgeson is an inventor based in San Francisco, California, and is associated with Bigfoot Biomedical, Inc. His patent work addresses technology intended to support insulin delivery and help users manage injection-site selection.
Latest Patents
The available information identifies one patent associated with Helgeson: “Injection Site Determination Systems and Methods for Injection Site Tracking and Recommending Injection Sites.” The method detects an upcoming insulin dose, identifies an injection site to recommend, and sends the recommendation to a delivery device for display. It also allows users to select injection sites and an injection cycle to create a personalized recommendation profile. Helgeson is credited with 1 patent.
Career Highlights
Helgeson’s documented innovation focuses on injection-site tracking and recommendations for insulin delivery. The described system combines dose-event detection, user preferences, and device-based recommendations to guide site selection.
Collaborations
The provided information associates Helgeson with Bigfoot Biomedical, Inc., a company working in the diabetes-care technology field. The patent description reflects an approach that connects user-selected preferences with recommendations presented through a delivery device.
Conclusion
Stuart Helgeson’s identified patent centers on personalized injection-site recommendations designed to support insulin delivery and tracking.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile